1. Mozaffari, Khashayar, Mekonnen, Mahlet, Harary, Maya, Wadehra, Madhuri, Yang, Isaac. 2022. Epithelial membrane protein 2 (EMP2): A systematic review of its implications in pathogenesis. In Acta histochemica, 125, 151976. doi:10.1016/j.acthis.2022.151976. https://pubmed.ncbi.nlm.nih.gov/36455339/
2. Enkhtaivan, Enkhmend, Kim, Hyun Ji, Kim, Boram, Lee, Ai Young, Lee, Chang Hoon. . Loss of EMP2 Inhibits Melanogenesis of MNT1 Melanoma Cells via Regulation of TRP-2. In Biomolecules & therapeutics, 30, 203-211. doi:10.4062/biomolther.2022.001. https://pubmed.ncbi.nlm.nih.gov/35221300/
3. Talia, Marianna, Cesario, Eugenio, Cirillo, Francesca, Maggiolini, Marcello, Lappano, Rosamaria. 2024. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. In Journal of translational medicine, 22, 597. doi:10.1186/s12967-024-05413-2. https://pubmed.ncbi.nlm.nih.gov/38937754/
4. Dillard, Christen, Kiyohara, Meagan, Mah, Vei, Wicha, Max S, Wadehra, Madhuri. 2020. EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells. In Molecular cancer therapeutics, 19, 1682-1695. doi:10.1158/1535-7163.MCT-19-0850. https://pubmed.ncbi.nlm.nih.gov/32451329/
5. Kiyohara, M H, Dillard, C, Tsui, J, Wicha, M S, Wadehra, M. 2017. EMP2 is a novel therapeutic target for endometrial cancer stem cells. In Oncogene, 36, 5793-5807. doi:10.1038/onc.2017.142. https://pubmed.ncbi.nlm.nih.gov/28604744/
6. Tian, Zemin, Yang, Shize. 2023. Integrating the characteristic genes of macrophage pseudotime analysis in single-cell RNA-seq to construct a prediction model of atherosclerosis. In Aging, 15, 6361-6379. doi:10.18632/aging.204856. https://pubmed.ncbi.nlm.nih.gov/37421595/
智鼠故事 
